Research Topics
| James S TomlinsonSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
Accuracy of staging node-negative pancreas cancer: a potential quality measureJames S Tomlinson
Center for Surgical Outcomes and Quality, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
Arch Surg 142:767-723; discussion 773-4. 2007..To determine the optimal number of lymph nodes to examine for accurate staging of node-negative pancreatic adenocarcinoma after pancreaticoduodenectomy...
Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisalIrina Yermilov
Department of Surgery, Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA
Ann Surg Oncol 16:554-61. 2009..Fifty-nine percent of patients were readmitted within 1 year after pancreaticoduodenectomy and 47% were readmitted to a secondary hospital...
Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomesNabil Wasif
John Wayne Cancer Institute at St John s Health Center, Santa Monica, California, USA
Cancer 116:3369-77. 2010..The authors compared survival and identify prognostic factors after resection for invasive IPMN versus stage-matched PAC...- Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patientsKarl Y Bilimoria
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Ann Surg 247:490-500. 2008..The objective of this study was to identify factors predicting survival after pancreatectomy for PNETs and to establish a postresection prognostic score... - Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitalsKarl Y Bilimoria
Department of Surgery, Feinberg School of Medicine, Northwestern University, 675 N St Clair St, Galter 10 105, Chicago, IL 60611, USA
Am J Surg 194:588-93. 2007..The objective of this study was to examine treatment utilization and outcomes for localized pancreatic cancer at VA compared with non-VA hospitals... - Utilization of parenteral nutrition following pancreaticoduodenectomy: is routine jejunostomy tube placement warranted?Irina Yermilov
Department of Surgery, VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd, Los Angeles, CA 90073, USA
Dig Dis Sci 54:1582-8. 2009..This study analyzes the utilization of parenteral nutrition (TPN) during the surgical admission as evidence for or against routine jejunostomy placement... - Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumorsKarl Y Bilimoria
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
J Am Coll Surg 205:558-63. 2007..Our objective was to evaluate the feasibility of applying the AJCC pancreatic adenocarcinoma staging system to PNETs... - Quality of care in advanced ovarian cancer: the importance of provider specialtyCheryl Mercado
Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 6904, USA
Gynecol Oncol 117:18-22. 2010..We examined whether surgeon specialty impacts quality of life (as proxied by presence of ostomy) and overall survival for women with advanced ovarian cancer... - Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging?Nabil Wasif
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
Ann Surg Oncol 17:2312-20. 2010..We hypothesized that tumor grade might be responsible for some of this variation and that the addition of grade to current AJCC staging would provide improved prognostication... - Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgeryTimothy R Donahue
Division of General Surgery, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095 6904, USA
Arch Surg 146:836-43. 2011.... - Survival after resection of ampullary carcinoma: a national population-based studyJessica B O'Connell
Department of Surgery, Geffen School of Medicine at UCLA, CHS, Rm 72 215, 10833 Le Conte Ave, Los Angeles, CA, 90095, USA
Ann Surg Oncol 15:1820-7. 2008..Our objective was to complete a population-based analysis of patients undergoing resection for ampullary carcinoma and compare it with outcomes in the published literature... - Are 12 nodes needed to accurately stage T1 and T2 colon cancers?Melinda A Maggard
Department of Surgery, Geffen School of Medicine at UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095, USA
Dig Dis Sci 54:640-7. 2009..For T1 tumors, 4 nodes had 24% lower hazard of death compared to <4. For T2 tumors, 10 nodes had the biggest survival impact, 15% lower hazard of death. In conclusion, the number of nodes to stage T1 and T2 lesions may be <12... - Impact of adjuvant radiation on survival: a note of caution when using cancer registry data to evaluate adjuvant treatmentsKarl Y Bilimoria
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
Ann Surg Oncol 14:3321-7. 2007..Our objective is to evaluate the potential impact the absence of adjuvant chemotherapy data has on the estimated survival benefit attributed to adjuvant radiation therapy... - Trends, patterns, and outcomes in the management of malignant colonic polyps in the general population of the United StatesNabil Wasif
John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, California, USA
Cancer 117:931-7. 2011..The goal of this study was to analyze trends and patterns in the surgical treatment of MPs and to assess outcomes as measured by lymph node retrieval and patient survival... - Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volumeKarl Y Bilimoria
Division of Surgical Oncology, Department of Surgery, Northwestern University, Chicago, Illinois, USA
Cancer 110:1227-34. 2007..The purpose of the current study was to evaluate multimodality therapy utilization and outcomes relative to hospital type and volume... - Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patientsKarl Y Bilimoria
Division of Surgical Oncology, Department of Surgery, Northwestern Memorial Hospital, Northwestern University, Feinberg School of Medicine, 675 N St Clair, Galter 10 105, Chicago, IL 60611, USA
J Gastrointest Surg 11:1460-7; discussion 1467-9. 2007..There are disparities in the utilization of pancreatectomy for PNETs. As PNETs have a better prognosis than adenocarcinoma, concerns regarding the morbidity and mortality of pancreatic surgery and neoplasms should not preclude resection... - Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody FragmentMark D Girgis
Department of Surgery, UCLA, 10833 LeConte Ave, Rm 54 140, Los Angeles, CA 90095, USA
EJNMMI Res 1:24. 2011..abstract:.. - An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumorsKatelyn E McCabe
Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA
Mol Imaging Biol 14:336-47. 2012..The purpose of this study was to generate and evaluate a positron emission tomography (PET) radiotracer targeting activated leukocyte cell adhesion molecule (ALCAM)... - Unexpected readmissions after major cancer surgery: an evaluation of readmissions as a quality-of-care indicatorMatthew M Rochefort
Department of Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Room 54 140 CHS, Box 9511782, Los Angeles, CA 90095 1782, USA
Surg Oncol Clin N Am 21:397-405, viii. 2012..Discharge processes and outpatient healthcare utilization can be improved. Until studies on readmission rate are conducted, using readmission rates as a measure of quality should be pursued cautiously... - Cystic neoplasms of the pancreas: results of 114 casesTimothy R Donahue
Division of General Surgery, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, CA 90095 6904, USA
Pancreas 39:1271-6. 2010..To identify clinical, radiographic, and histopathologic characteristics associated with cancer in cystic pancreatic neoplasms and to evaluate our preoperative diagnostic accuracy to predict cancer in such cysts... - Comorbidities play a larger role in predicting health-related quality of life compared to having an ostomySushma Jain
Center for Surgical Outcomes and Quality, Department of Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095, USA
Am J Surg 194:774-9; discussion 779. 2007..Previous research suggests an ostomy worsens health-related quality of life (HR-QOL), but comorbidities also can affect HR-QOL... - Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survivalCristina R Ferrone
Memorial Sloan Kettering Cancer Center, Department of Surgery, 1275 York Ave, Box 435, New York, NY 10021, USA
J Clin Oncol 23:7529-35. 2005..A single US institution database was used to test the validity of the pancreatic adenocarcinoma nomogram established at Memorial Sloan-Kettering Cancer Center... - Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasmRaymond S Tang
Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, California 951693, USA
Clin Gastroenterol Hepatol 6:815-9; quiz 719. 2008..We aimed to evaluate the surgical characteristics of these guidelines retrospectively in pathologically confirmed cases of BD-IPMN... - Quality of care in surgical oncologySierra R Matula
Robert Wood Johnson Clinical Scholars Program, University of California, Los Angeles, Los Angeles, California 90024, USA
Cancer Control 16:303-11. 2009..A current focus on quality assessment and improvement in oncology care, specifically in surgical oncology, is aimed toward providing optimal health services that consistently fulfill these elements for cancer patients... - Actual 10-year survival after resection of colorectal liver metastases defines cureJames S Tomlinson
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 25:4575-80. 2007..There is now sufficient follow-up on a significant number of patients to address the curative intent of resecting CLM... - Anti-CA19-9 diabody as a PET imaging probe for pancreas cancerMark D Girgis
Department of Surgery, UCLA, Los Angeles, California 90095, USA
J Surg Res 170:169-78. 2011..Our goal was to develop and characterize the anti-CA19-9 diabody fragment and determine its ability to provide antigen specific imaging of pancreas cancer... - Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinomaMary L Alpaugh
Department of Pathology, UCLA School of Medicine, Los Angeles, California, CA 90024, USA
Oncogene 21:3631-43. 2002..1). Our findings support the cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in IBC... - Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancerKarl Y Bilimoria
Cancer Programs, American College of Surgeons, Chicago, Illinois, USA
Arch Surg 143:671-8; discussion 678. 2008....